# Mogling Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mogling-bio

- Industry: Biotechnology
- Headquarters: Wilmington, US
- Website: www.moglingbio.com
- Latest round: Seed (Oct 26, 2022)
- Investors on record: 1

## About

Based in Delaware, US, Mogling Bio treats old blood cell formation systems to rejuvenate in a pharmacological way. In October 2022, the firm raised a specific amount of Seed funding from KIZOO Technology Ventures. The company was co-founded by Jurgen Reeb, Yi Zheng, and Hartmut Geiger.

The company develops new pharmacological approaches which help in rejuvenating old stem cells of the hematopoietic (blood cell formation) system. It helps in normalizing CDC42 activity as well as restoring structure, order, and functionality in aged stem cells. The firm approaches contribute to both, the rejuvenation of stem cells and the immune system.

The company plans to use the October 2022 funding to expand its market reach and accelerate its product development.

## Funding rounds

- Seed, Oct 26, 2022 — KIZOO Technology Ventures

## Investors

- KIZOO Technology Ventures (https://capitalatlas.ai/funds/kizoo-technology-ventures) — Seed